LS Investment Advisors’s Regenxbio RGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-2,436
Closed -$90K 1300
2020
Q2
$90K Buy
2,436
+108
+5% +$4.03K 0.01% 1018
2020
Q1
$75K Hold
2,328
0.01% 999
2019
Q4
$95K Hold
2,328
0.01% 1127
2019
Q3
$83K Hold
2,328
﹤0.01% 1133
2019
Q2
$120K Hold
2,328
0.01% 1014
2019
Q1
$133K Buy
2,328
+68
+3% +$3.37K 0.01% 973
2018
Q4
$95K Buy
2,260
+874
+63% +$51.3K 0.01% 1078
2018
Q3
$105K Buy
1,386
+134
+11% +$9.65K 0.01% 1115
2018
Q2
$90K Buy
+1,252
New +$59.8K 0.01% 1167

Other funds holding RGNX

LS Investment Advisors's RGNX Position: Q3 2020 in Review

LS Investment Advisors sold out of Regenxbio (RGNX) in Q3 2020, closing a stake of 2,436 shares — an estimated $90K sold.

LS Investment Advisors first reported a position in RGNX in Q2 2018 and held it in 9 quarters. The position peaked at $133K in Q1 2019. 166 funds tracked by Wall St. Rank hold RGNX as of Q3 2020.

  • LS Investment Advisors reported no remaining Regenxbio position as of Q3 2020 after selling out during the quarter.
  • LS Investment Advisors sold 2,436 Regenxbio shares in Q3 2020, an estimated $90K.
  • LS Investment Advisors first reported a position in Regenxbio in Q2 2018 and held it in 9 quarters.
  • LS Investment Advisors's Regenxbio position peaked at $133K in Q1 2019.
  • 166 funds tracked by Wall St. Rank held Regenxbio as of Q3 2020.

Based on LS Investment Advisors's 13F filing for Q3 2020, filed 12 Nov 2020.